JP Morgan Maintains Neutral on Alkermes, Raises Price Target to $61

Benzinga Newsdesk www.benzinga.com Neutral 54.3%

Neg 0% Neu 54.3% Pos 0%

JP Morgan analyst Jessica Fye maintains Alkermes (NASDAQ:ALKS) with a Neutral and raises the price target from $60 to $61.